Literature DB >> 349598

Baclofen in the treatment of tardive dyskinesia and schizophrenia.

G M Simpson, J H Lee, R K Shrivastava, M H Branchey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 349598

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  4 in total

1.  Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities.

Authors:  S Mithani; S Atmadja; K G Baimbridge; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  The treatment of tardive dyskinesia with baclofen.

Authors:  W M Glazer; D C Moore; M B Bowers; B S Bunney; M Roffman
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

3.  GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction.

Authors:  M J Gandal; J Sisti; K Klook; P I Ortinski; V Leitman; Y Liang; T Thieu; R Anderson; R C Pierce; G Jonak; R E Gur; G Carlson; S J Siegel
Journal:  Transl Psychiatry       Date:  2012-07-17       Impact factor: 6.222

Review 4.  Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia.

Authors:  Samer Alabed; Youssef Latifeh; Husam Aldeen Mohammad; Hanna Bergman
Journal:  Cochrane Database Syst Rev       Date:  2018-04-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.